Broad and ERS Genomics both claim victory in latest CRISPR ruling
14-09-2020
Broad Institute presses for CRISPR settlement after EPO revocation
23-01-2020
Vchal / Shutterstock.com
ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
ERS Genomics, Michael Arciero, CRISPR, CRISPR/Cas9, intellectual property, USC Stevens Center for Innovation, genetics, technology transfer
